November 3, 2024

We’re thrilled to announce that Dyania Health, a Motivate Ventures Fund I portfolio company, raised a $10M Series A from HealthX, Cleveland Clinic Ventures and Tech Square Ventures.

Over the past four years, Founder and CEO Eirini Schlosser and her world class team have been working tirelessly to develop Synapsis AI—a platform built on a specialized LLM that streamlines manual chart review and patient pre-screening for clinical trials. Dyania’s platform currently helps large healthcare systems automate complex tasks like chart reviews for observational studies, registry reporting, and trial pre-screening.

Synapsis AI can analyze vast datasets in seconds, reaching over 94% accuracy at a staggering 15,000 times faster when compared to human professionals, all within the healthcare system’s firewall, avoiding any external data mining. With its speed, accuracy and security, Synapsis AI will transform how healthcare systems handle vast amounts of medical data, opening up exciting possibilities for fast, data-driven decision-making across the healthcare landscape.

Most importantly, this will have a massive impact for patients, providing easy access to clinical trials and dramatically accelerating scientific progress.

The Dyania team combines expertise from Amazon Alexa AI, Bloomberg AI, Flatiron Health, and NYU Langone. With more than 800 academic publications and vast experience in AI and applied mathematics, clinical research, medicine, drug development and EMR workflows, Dyania Health brings together knowledge from top tech and health companies to build a powerful platform that combines medical expertise with technical innovation.

Since the initial pre-seed round, we’ve been inspired by Dyania Health’s gigantic vision and relentless drive to transform the clinical trial market. The entire Motivate family is thrilled to see what lies ahead for this powerful, important technology and Eirini and her exceptional team.